reference/33503801

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/33503801

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	275
issn	1432-0584 0939-5555
issueIdentifier	5
pageRange	270-275
publicationName	Annals of Hematology
startingPage	270
bibliographicCitation	Leaw SJ, Yen CJ, Huang WT, Chen TY, Su WC, Tsao CJ. Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy. Ann Hematol. 2004 May;83(5):270–5. doi: 10.1007/s00277-003-0825-8. PMID: 15060745.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7bf8cdbf24ca6bcd44966c8af200335b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f856d7921fb1fcb6a5fb9557106580a8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4a9894a8b35bcbe778a1fc8cdbc572cc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_74fac5d4d26888e5e41d2dfa9c78bcf7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_70b6dc635d29834ab7424f2e2b1dba70 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ca289e5279b236cfec2fcfa1c777efdf
date	2004-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/15060745 https://doi.org/10.1007/s00277-003-0825-8
isPartOf	https://portal.issn.org/resource/ISSN/1432-0584 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1088 https://portal.issn.org/resource/ISSN/0939-5555
language	English
source	https://www.crossref.org/ https://scigraph.springernature.com/ https://pubmed.ncbi.nlm.nih.gov/
title	Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy
discusses	http://id.nlm.nih.gov/mesh/M0005485 http://id.nlm.nih.gov/mesh/M0010217 http://id.nlm.nih.gov/mesh/M0028255 http://id.nlm.nih.gov/mesh/M0001518 http://id.nlm.nih.gov/mesh/M0022676 http://id.nlm.nih.gov/mesh/M0017465 http://id.nlm.nih.gov/mesh/M0025711 http://id.nlm.nih.gov/mesh/M0023488 http://id.nlm.nih.gov/mesh/M0028682
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134755071 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45358158 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324671 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71296921 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62313 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388993 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8388 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164145 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7989 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7987 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60825 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9981 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3717450 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7d6a1edc08997e3d7b61d7a07051efb5 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID243743787 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128324017 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136090536

Total number of triples: 58.